Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

April 16, 2024

https://www.globenewswire.com/news-release/2024/04/16/2863491/0/en/Organogenesis-Holdings-Inc-to-Report-First-Quarter-of-Fiscal-Year-2024-Financial-Results-on-May-9-2024.html

CANTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq:ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that first quarter of fiscal year 2024 financial results will be reported after the market closes on Thursday, May 9th.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.